{"id":"https://openalex.org/W2076753181","doi":"https://doi.org/10.1016/j.phrs.2009.03.013","title":"Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT4 receptor","display_name":"Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT4 receptor","publication_year":2009,"publication_date":"2009-04-02","ids":{"openalex":"https://openalex.org/W2076753181","doi":"https://doi.org/10.1016/j.phrs.2009.03.013","mag":"2076753181","pmid":"https://pubmed.ncbi.nlm.nih.gov/19717010"},"language":"en","primary_location":{"id":"doi:10.1016/j.phrs.2009.03.013","doi":"https://doi.org/10.1016/j.phrs.2009.03.013","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.phrs.2009.03.013","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063705695","display_name":"Tohru Komada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tohru Komada","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tomomi Matsuura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomomi Matsuura","raw_affiliation_strings":["Pharmacokinetics, Dynamics & Metabolism, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics & Metabolism, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111651664","display_name":"Tadayoshi Mikami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadayoshi Mikami","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Keiko Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiko Suzuki","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108528297","display_name":"Hiromi Sugimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromi Sugimoto","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Naoji Kimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoji Kimura","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113520460","display_name":"Takashi Ohmi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Ohmi","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059962047","display_name":"Tetsuo Toga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuo Toga","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112547748","display_name":"Yasuhiro Nakai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiro Nakai","raw_affiliation_strings":["Pharmacokinetics, Dynamics & Metabolism, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics & Metabolism, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059906767","display_name":"Hiroyuki Eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroyuki Eda","raw_affiliation_strings":["Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan","institution_ids":["https://openalex.org/I4210148786"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5059906767"],"corresponding_institution_ids":["https://openalex.org/I4210148786"],"apc_list":{"value":4130,"currency":"USD","value_usd":4130},"apc_paid":null,"fwci":0.1099,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.45320735,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"60","issue":"4","first_page":"237","last_page":"246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.06480000168085098,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0272000003606081,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht4-receptor","display_name":"5-HT4 receptor","score":0.8799999952316284},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.7739999890327454},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7049999833106995},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/gastric-motility","display_name":"gastric motility","score":0.8769999742507935},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.8240000009536743},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.37599998712539673},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.5479999780654907},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.5649999976158142},{"id":"https://openalex.org/keywords/herg-channel","display_name":"hERG","score":0.6700000166893005},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.7929767966270447},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.759406328201294},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.6854771375656128},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6479737758636475},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6075646877288818},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5649516582489014},{"id":"https://openalex.org/C192096249","wikidata":"https://www.wikidata.org/wiki/Q18027442","display_name":"5-HT4 receptor","level":4,"score":0.5119575262069702},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4644925892353058},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.45288705825805664},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4126686155796051},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.3337218165397644},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33152246475219727},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33121925592422485},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24751058220863342},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24413520097732544},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1592264473438263},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003503","descriptor_name":"Cyclobutanes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003503","descriptor_name":"Cyclobutanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004947","descriptor_name":"Esophagus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004947","descriptor_name":"Esophagus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005764","descriptor_name":"Gastroesophageal Reflux","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005769","descriptor_name":"Gastrointestinal Motility","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009130","descriptor_name":"Muscle, Smooth","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009130","descriptor_name":"Muscle, Smooth","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044422","descriptor_name":"Receptors, Serotonin, 5-HT4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058828","descriptor_name":"Serotonin 5-HT4 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.phrs.2009.03.013","doi":"https://doi.org/10.1016/j.phrs.2009.03.013","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.phrs.2009.03.013","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},{"id":"pmid:19717010","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19717010","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W161356906","https://openalex.org/W317690388","https://openalex.org/W1702556248","https://openalex.org/W1858131570","https://openalex.org/W1918687998","https://openalex.org/W1965625617","https://openalex.org/W1966746671","https://openalex.org/W1968098810","https://openalex.org/W1975661708","https://openalex.org/W1976200262","https://openalex.org/W1977859950","https://openalex.org/W1992768650","https://openalex.org/W1994624994","https://openalex.org/W1999933643","https://openalex.org/W2000535235","https://openalex.org/W2002858990","https://openalex.org/W2003117333","https://openalex.org/W2004862250","https://openalex.org/W2008373894","https://openalex.org/W2011345948","https://openalex.org/W2017815761","https://openalex.org/W2019678016","https://openalex.org/W2028221809","https://openalex.org/W2029232191","https://openalex.org/W2029982117","https://openalex.org/W2030183206","https://openalex.org/W2041238628","https://openalex.org/W2043829453","https://openalex.org/W2044025853","https://openalex.org/W2051712524","https://openalex.org/W2053124111","https://openalex.org/W2053958220","https://openalex.org/W2059219549","https://openalex.org/W2066900142","https://openalex.org/W2068454300","https://openalex.org/W2069643295","https://openalex.org/W2072967140","https://openalex.org/W2073461076","https://openalex.org/W2074705578","https://openalex.org/W2076239091","https://openalex.org/W2076826596","https://openalex.org/W2078852369","https://openalex.org/W2085048839","https://openalex.org/W2085104727","https://openalex.org/W2085374754","https://openalex.org/W2086925294","https://openalex.org/W2090842596","https://openalex.org/W2100471791","https://openalex.org/W2111017095","https://openalex.org/W2145533362","https://openalex.org/W2159947898","https://openalex.org/W2161121905","https://openalex.org/W2163161835","https://openalex.org/W2171818436","https://openalex.org/W2213953966","https://openalex.org/W2225465581","https://openalex.org/W2227487616","https://openalex.org/W2232346553","https://openalex.org/W2308049205"],"related_works":["https://openalex.org/W2012837477","https://openalex.org/W2007133271","https://openalex.org/W2330940815","https://openalex.org/W2093366809","https://openalex.org/W7096310992","https://openalex.org/W2066900142","https://openalex.org/W1982211349","https://openalex.org/W2157825392","https://openalex.org/W2336663006","https://openalex.org/W2106880509"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}